• 대한한방내과학회지
• /
• 제39권1호
• /
• pp.69-75
• /
• 2018

Objectives: This study was designed to report the effect of HongYi pharmacopuncture on three cases of severe female urinary disorder. Method: Patients were treated with HongYi pharmacopuncture alone for 4 weeks. The effect of treatment was assessed through scores obtained using International Prostate Symptom Score (IPSS) and International Consultation on Incontinence Modular Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS). Result: After treatment, urinary symptoms, and the scores of IPSS and ICIQ-FLUTS were improved in all of the patients. Conclusion: HongYi pharmacopuncture shows a significant beneficial effect on female urination disorder. Further well-designed, controlled studies and more cases are needed to define the effect of HongYi pharmacopuncture.

• 대한한방내과학회지
• /
• 제38권6호
• /
• pp.930-943
• /
• 2017

Objectives: The purpose of this study was to investigate the clinical effects of HongYi pharmacopuncture monotherapy on female voiding dysfunction. Methods: Korean medical practitioners who used HongYi pharmacopuncture to treat female patients complaining of dysuria were surveyed. They performed a retrospective chart review of 31 female patients who visited their Korean medical clinic for dysuria. General characteristics, marital status, urologic medical history, International Prostate Symptom Score (IPSS), International Consultation on Incontinence Modular Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS), and related adverse events were examined. Results: Of 31 cases received, 29 were selected for analysis. Two cases were excluded because treatment was not continued through four weeks. In all cases, IPSS and ICIQ-FLUTS scores were significantly decreased after treatment. Adverse reactions occurred during treatment in four cases. Conclusions: These results suggest that treatment by HongYi pharmacopuncture is effective in improving lower urinary tract symptoms in women. Further studies will be needed for evaluation of clinical responses, to evaluate the safety and efficacy of HongYi pharmacopuncture treatment for female patients complaining of dysuria.